• Citer

Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.

par Burzykowski, T.;Buyse, Marc;Piccart-Gebhart, Martine ;Sledge, G.;Carmichael, J.;Luck, H. J.;Mackey, John R;Nabholtz, J.M.;Paridaens, R. ;Biganzoli, Laura ;Jassem, J.;Bontenbal, M;Bonneterre, J;Chan, S;Basaran, Gul;Therasse, P.
Référence Journal of clinical oncology, 26, 12, page (1987-1992)
Publication Publié, 2008-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.
Auteur:	Burzykowski, T.; Buyse, Marc; Piccart-Gebhart, Martine; Sledge, G.; Carmichael, J.; Luck, H. J.; Mackey, John R; Nabholtz, J.M.; Paridaens, R.; Biganzoli, Laura; Jassem, J.; Bontenbal, M; Bonneterre, J; Chan, S; Basaran, Gul; Therasse, P.
Informations sur la publication:	Journal of clinical oncology, 26, 12, page (1987-1992)
Statut de publication:	Publié, 2008-04
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Anthracyclines -- administration & dosage
	Anthracyclines -- therapeutic use
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Biological Markers
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- pathology
	Disease-Free Survival
	Female
	Humans
	Neoplasm Metastasis
	Proportional Hazards Models
	Randomized Controlled Trials as Topic -- methods
	Reproducibility of Results
	Survival Rate
	Taxoids -- administration & dosage
	Taxoids -- therapeutic use
	Treatment Outcome
Note générale:	Journal Article
	Meta-Analysis
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2007.10.8407
	info:pii/26/12/1987
	info:pmid/18421050